In last trading session, Wave Life Sciences Ltd (NASDAQ:WVE) saw 1.49 million shares changing hands with its beta currently measuring -1.04. Company’s recent per share price level of $10.81 trading at $0.41 or 3.94% at ring of the bell on the day assigns it a market valuation of $1.66B. That closing price of WVE’s stock is at a discount of -54.86% from its 52-week high price of $16.74 and is indicating a premium of 60.68% from its 52-week low price of $4.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.41 million shares which gives us an average trading volume of 1.00 million if we extend that period to 3-months.
For Wave Life Sciences Ltd (WVE), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.18. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Wave Life Sciences Ltd (NASDAQ:WVE) trade information
Upright in the green during last session for gaining 3.94%, in the last five days WVE remained trading in the green while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $10.81 price level, adding 1.37% to its value on the day. Wave Life Sciences Ltd’s shares saw a change of -12.61% in year-to-date performance and have moved 2.27% in past 5-day. Wave Life Sciences Ltd (NASDAQ:WVE) showed a performance of 1.41% in past 30-days. Number of shares sold short was 9.16 million shares which calculate 11.54 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 22 to the stock, which implies a rise of 50.86% to its current value. Analysts have been projecting 15 as a low price target for the stock while placing it at a high target of 36. It follows that stock’s current price would drop -38.76% in reaching the projected high whereas dropping to the targeted low would mean a loss of -38.76% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 34.27% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -36.98% while estimates for its earnings growth in next 5 years are of 34.50%.
Wave Life Sciences Ltd (NASDAQ:WVE)’s Major holders
Insiders are in possession of 16.53% of company’s total shares while institution are holding 83.51 percent of that, with stock having share float percentage of 100.04%. Investors also watch the number of corporate investors in a company very closely, which is 83.51% institutions for Wave Life Sciences Ltd that are currently holding shares of the company. RA CAPITAL MANAGEMENT, L.P. is the top institutional holder at WVE for having 18.2 million shares of worth $90.83 million. And as of 2024-06-30, it was holding 14.0527 of the company’s outstanding shares.
The second largest institutional holder is MAVERICK CAPITAL LTD, which was holding about 7.67 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.9211 of outstanding shares, having a total worth of $38.27 million.
